Evaluation of changes in mammographic breast density associated with bazedoxifene, raloxifene, and placebo in postmenopausal women: an ancillary study of protocol 3068A1-301-WW
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2010
At a glance
- Drugs Bazedoxifene; Raloxifene
- Indications Menopause
- Focus Pharmacodynamics
- Sponsors Pfizer; Wyeth
- 17 Aug 2010 Actual end date changed from Sep 2007 to Apr 2010 as reported by ClinicalTrials.gov.
- 04 Dec 2007 Status change from in progress to completed.
- 18 Jan 2007 New trial record.